Nutraplus India Limited Submits Q4 FY26 Compliance Certificate Under SEBI Regulations
Nutraplus India Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26 ended March 31, 2026. The certificate from registrar MUFG Intime India Private Limited confirms proper handling of dematerialized securities and compliance with prescribed timelines for all regulatory requirements during the quarter.
*this image is generated using AI for illustrative purposes only.
Nutraplus India Limited has submitted its mandatory quarterly compliance certificate to the Bombay Stock Exchange for the quarter ended March 31, 2026. The submission fulfills requirements under Regulation 74(5) of the Securities and Exchange Board of India (Depositories & Participants) Regulations, 2018.
Regulatory Compliance Details
The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), which serves as the company's Registrar and Share Transfer Agent. The document confirms that all securities received from depository participants for dematerialization during the quarter were properly processed and confirmed to the depositories within prescribed timelines.
| Parameter: | Details |
|---|---|
| Quarter Period: | Ended March 31, 2026 |
| Regulation: | SEBI (Depositories & Participants) Regulations, 2018 - Section 74(5) |
| Registrar: | MUFG Intime India Private Limited |
| BSE Scrip Code: | 524764 |
| Submission Date: | April 14, 2026 |
Certificate Confirmation
The registrar's certificate confirms several key compliance aspects:
- Securities received for dematerialization were confirmed or rejected to depositories as required
- All securities comprised in certificates have been listed on stock exchanges where previously issued securities are traded
- Security certificates received for dematerialization were properly mutilated and cancelled after verification
- Depository names were substituted in the register of members as registered owners within prescribed timelines
Company Background
Nutraplus India Limited operates as a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is located at Plot No. N-92, MIDC Tarapur, Boisar, Thane, and trades on the Bombay Stock Exchange under scrip code 524764.
The submission was signed by Mukesh Naik, Managing Director (DIN: 00412896), and represents routine regulatory compliance required of all listed companies in India.
How might Nutraplus India's API manufacturing business be positioned to benefit from India's growing pharmaceutical export opportunities in 2026?
What impact could the recent transition from Link Intime to MUFG Intime have on Nutraplus India's investor relations and share transfer processes?
Will Nutraplus India consider expanding its stock exchange listings beyond BSE to improve liquidity and market visibility?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
